1. Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
- Author
-
Jittamala, Podjanee, primary, Boyd, Simon, additional, Schilling, William Henry Keith, additional, Watson, James Andrew, additional, Ngamprasertchai, Thundon, additional, Siripoon, Tanaya, additional, Luvira, Viravarn, additional, Batty, Elizabeth M, additional, Wongnak, Phrutsamon, additional, Esper, Lisia M, additional, Almeida, Pedro J, additional, Cruz, Cintia, additional, Ascencao, Fernando R, additional, Aguiar, Renato S, additional, Ghanchi, Najia K, additional, Callery, James J, additional, Singh, Shivani, additional, Kruabkontho, Varaporn, additional, Ngernseng, Thatsanun, additional, Tubprasert, Jaruwan, additional, Madmanee, Wanassanan, additional, Suwannasin, Kanokon, additional, Promsongsil, Amornrat, additional, Hanboonkunupakarn, Borimas, additional, Poovorawan, Kittiyod, additional, Potaporn, Manus, additional, Srisubat, Attasit, additional, Loharjun, Bootsakorn, additional, Taylor, Walter RJ, additional, Qamar, Farah N, additional, Kazi, Abdul Momin, additional, Beg, M Asim, additional, Chommanam, Danoy, additional, Vidhamaly, Sisouphanh, additional, Chotivanich, Kesinee, additional, Imwong, Mallika, additional, Pukrittayakamee, Sasithon, additional, Dondorp, Arjen M, additional, Day, Nicholas PJ, additional, Teixeira, Mauro M, additional, Piyaphanee, Watcharapong, additional, Phumratanaprapin, Weerapong, additional, and White, Nicholas J, additional
- Published
- 2024
- Full Text
- View/download PDF